MedTrace Logo

Transdiagnostic Versus Diagnosis-specific Cognitive-behavioral Therapy

NCT05249543 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2026-03-24

No results posted yet for this study

Summary

The primary aim of the pilot study is to investigate the feasibility of conducting a randomized controlled trial (RCT) comparing the effects of transdiagnostic and diagnosis-specific cognitive-behavioral therapy (CBT) for patients with anxiety disorders in routine psychiatric outpatient care in Stockholm, Sweden. It is hypothesized that an RCT is feasible in terms of recruitment, retention, therapist competence and adherence to treatments, and that the treatments are well received by participants.

Conditions

Interventions

BEHAVIORAL

Unified protocol

Transdiagnostic cognitive-behavioral therapy

BEHAVIORAL

Diagnosis-specific cognitive-behavioral therapy

Diagnosis-specific cognitive-behavioral therapy

Sponsors & Collaborators

Principal Investigators

  • Benjamin Bohman, PhD · Karolinska Institutet

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-01
Primary Completion
2026-06-30
Completion
2026-06-30

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05249543 on ClinicalTrials.gov